- Home
- RCUS vs TENB Comparison
RCUS vs TENB Comparison
Compare RCUS & TENB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RCUS | TENB |
|---|---|---|
| Founded | 2015 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Computer Software: Prepackaged Software |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 3.1B | 3.5B |
| IPO Year | 2018 | 2018 |
Fundamental Metrics
Financial Performance| Metric | RCUS | TENB |
|---|---|---|
| Price | $21.31 | $24.89 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 8 | 17 |
| Target Price | $29.38 | ★ $39.25 |
| AVG Volume (30 Days) | ★ 2.1M | 1.1M |
| Earning Date | 10-28-2025 | 10-29-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $240,000,000.00 | ★ $974,603,000.00 |
| Revenue This Year | N/A | $12.22 |
| Revenue Next Year | N/A | $7.62 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | N/A | ★ 11.05 |
| 52 Week Low | $6.50 | $25.28 |
| 52 Week High | $26.40 | $45.45 |
Technical Indicators
Market Signals| Indicator | RCUS | TENB |
|---|---|---|
| Relative Strength Index (RSI) | 41.72 | 30.84 |
| Support Level | $20.35 | $26.11 |
| Resistance Level | $26.10 | $27.24 |
| Average True Range (ATR) | 1.48 | 0.62 |
| MACD | -0.61 | 0.02 |
| Stochastic Oscillator | 15.21 | 11.54 |
Price Performance
Historical ComparisonAbout RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.
About TENB Tenable Holdings Inc.
Founded in 2002, Tenable is a cybersecurity company that began providing vulnerability management solutions under its Nessus software. In recent years, Tenable has expanded its portfolio to provide a broader range of exposure management modules. Solutions include cloud security and compliance, active directory management, operational technology security and advanced vulnerability analytics. The Maryland-based company went public in 2018.